RGT 3.33% 15.5¢ argent biopharma limited

Analysis of MXC when compared to CPH, page-54

  1. 1,049 Posts.
    lightbulb Created with Sketch. 241
    "Businesses of all shapes ans size do this kind of forecasting for project analysis, budgeting etc..."


    Forecast...glad you use this word! If it's a forecast it means the valuation can't be entirely accurate/subjective, especially MM is a NEW industry. 


    Book value is commonly deemed as the "net equity" of the company , have you noticed MXC has put this 7.02 million intangible assets under "equity" in their 2017 financial statement? I am not saying it's wrong to do that, but at least other MM company such as Auscann and CANN didn't do that.


    Lastly, let's use some common sense here. If I told you there is a company that makes around 120k revenue per year, have a net LOSS of around 6 million for the last 2 financial years, while its intangible assets is 7 millions. What's your thought?


    AIMO DYOR



 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
15.5¢
Change
0.005(3.33%)
Mkt cap ! $8.412M
Open High Low Value Volume
15.0¢ 15.5¢ 15.0¢ $110 715

Buyers (Bids)

No. Vol. Price($)
1 1047 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 1898 2
View Market Depth
Last trade - 13.36pm 27/12/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.